InsidersTradesSigma
Explore the detailed record of transactions filed by HOLLER FRANK A, Director. Officer active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 2 filings have been published. The latest transaction was disclosed on 27 May 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Frank A. Holler is a Board Member at Xenon Pharmaceuticals Inc. He plays a crucial role in the governance of the company, providing strategic advice and oversight of operations. His experience in the pharmaceutical sector allows him to contribute to the innovation and growth of Xenon Pharmaceuticals. As a board member, he participates in critical decision-making for the company's future.